Intellia Therapeutics (NTLA) Retained Earnings (2015 - 2026)
Intellia Therapeutics (NTLA) reported Retained Earnings of -$240000.0 for Q1 2026, up 99.99% year-over-year from -$120006.3 in Q1 2025, and down 123.26% quarter-over-quarter from $1.0 million in Q4 2025.
Intellia Therapeutics (NTLA) Retained Earnings (2015 - 2026) Analysis & Trends
Intellia Therapeutics (NTLA) has 12 years of Retained Earnings data on file, last reported at -$240000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$240000.0, up 99.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$240000.0 (up 99.99% YoY), and the FY2025 annual result was $1.0 million, up 70.58% from the prior year.
- Retained Earnings retreated to -$240000.0 in Q1 2026 per NTLA's latest filing, from $1.0 million in the prior quarter.
- Over five years, Retained Earnings peaked at $1.0 million in Q4 2025 and troughed at -$2.5 billion in Q3 2025.
- A 5-year average of -$1.1 billion and a median of -$1.2 billion in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings slumped 611267.82% in 2022, then soared 126.79% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$1.2 billion in 2022, then jumped by 99.81% to -$2.3 million in 2023, then soared by 126.79% to $605000.0 in 2024, then jumped by 70.58% to $1.0 million in 2025, then plunged by 123.26% to -$240000.0 in 2026.
- Business Quant data shows NTLA's Retained Earnings at -$240000.0 in Q1 2026, $1.0 million in Q4 2025, and -$2.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Intellia Therapeutics | 1.86 Bn | 1.86 Bn | - | -240,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -240,000.00 |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | -2.49 Bn |
| Jun 30, 2025 | -2.39 Bn |
| Mar 31, 2025 | -2.29 Bn |
| Dec 31, 2024 | 605,000.00 |
| Sep 30, 2024 | -2.05 Bn |
| Jun 30, 2024 | -1.91 Bn |
| Mar 31, 2024 | -1.77 Bn |
| Dec 31, 2023 | -2.26 Mn |
| Sep 30, 2023 | -1.53 Bn |
| Jun 30, 2023 | -3.87 Mn |
| Mar 31, 2023 | -1.28 Bn |
| Dec 31, 2022 | -1.18 Bn |
| Sep 30, 2022 | -1.06 Bn |
| Jun 30, 2022 | -950.55 Mn |
| Mar 31, 2022 | -8.06 Mn |
| Dec 31, 2021 | -2.63 Mn |
| Sep 30, 2021 | -174,000.00 |
| Jun 30, 2021 | -550.12 Mn |